Shigemitsu H, Nagai S, Sharma OP. Pulmonary hypertension and granulomatous vasculitis in sarcoidosis. Curr. Opin. Pulm. Med., 2007, 13: 434-8.
Battesti JP, Georges R, Basset F et al. Chronic cor pulmonale in pulmonary sarcoidosis. Thorax, 1978, 33: 76-84.
Rizzato G, Pezzano A, Sala G et al. Right heart impairment in sarcoidosis: haemodynamic and echocardiography study. Eur.JRespir. Dis, 1983, 64: 121-8.
Mayock RL, Bertrand P,Morrison CE et al. Manifestations of sarcoidosis. Analysis of 145 patients with a review of nine seriesselected from the literature. Am. J. Med., 1963, 35: 67-89.
Shorr AF, Helman DL, Davies DB et al. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur. Respir. J., 2005, 25: 783-788.
Orens JB, Estenne M, Arcasoy S et al. International guidelines for the selection of lung transplant candidates: 2006 update a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant, 2006, 25: 745-755.
Baughman RP, Engel PJ, Taylor L et al. Survival in sarcoidosis associated pulmonary hypertension: the importance of hemodynamic evaluation. Chest, 2010. DOI: 10.1378/09-2002..
DOI: 10.1378/09-2002
Baughman RP, Engel PJ, Meyer CA et al. Pulmonary hypertension in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis, 2006, 23: 108-116.
Rosen Y, Moon S, Huang CT et al. Granulomatous pulmonary angiitis in sarcoidosis. Arch. Pathol. Lab. Med, 1977, 101: 170-174.
Takemura T, Matsui Y, Saiki S et al. Pulmonary vascular involvement in sarcoidosis: a report of 40 autopsy cases. Hum. Pathol.,1992, 23: 1216-1223.
Sulica R, Teirstein AS, Kakarla S et al. Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. Chest, 2005, 128: 1483-1489.
Сперанская А.А. Комплексное компьютерно-томографическое и радионуклидное исследование в дифференциальной диагностике интерстициальных заболеваний легких. Дисс. канд. мед. наук. СПб., 2013.
Leuchte HH, Baumgartner RA, Nounou ME et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am. J. Respir. Crit. Care Med, 2006, 173: 744-750.
Corte TJ, Wort SJ, Gatzoulis MA et al. Elevated Brain natriuretic peptide predicts mortality in interstitial lung disease. Eur. Respir.)., 2010, 36: 819-25. DOI: 10.1183/09031936.00173509..
DOI: 10.1183/09031936.00173509
Handa T, Nagai S, Shigematsu M et al. Patient characteristics and clinical features of Japanese sarcoidosis patients with low bronchoalveolar lavage CD4/ CD8 ratios. Sarcoidosis Vasc. Diffuse Lung Dis, 2005, 22: 154-160.
Baughman RP Pulmonary hypertension associated with sarcoidosis. Arthritis Res. Ther, 2007, 9 (Suppl. 2): S8.
Rodman DM, Lindenfeld J. Successful treatment of sarcoidosis associated pulmonary hypertension with corticosteroids. Chest, 1990, 97: 500-502.
Mangla A, Fisher J, Libby DM et al. Sarcoidosis, pulmonary hypertension, and acquired peripheral pulmonary artery stenosis. Cathet. Cardiovasc Diagn, 1985, 11: 69-74.
Gluskowski J, Hawrylkiewicz I, Zych D et al. Effects of corticosteroid treatment on pulmonary haemodynamics in patients with sarcoidosis. Eur. Respir. J, 1990, 3: 403-407.
Damuth TE, Bower JS, Cho K et al. Major pulmonary artery stenosis causing pulmonary hypertension in sarcoidosis. Chest, 1980, 78: 888-91.
Barst RJ, Ratner SJ. Sarcoidosis and reactive pulmonary hypertension. Arch. Intern. Med, 1985, 145: 2112-2114.
Fisher KA, Serlin DM, Wilson KC et al. Sarcoidosis-associated pulmonary hypertension: outcome with long-termepoprostenol treatment. Chest, 2006, 130: 1481-1488.
Preston IR, Klinger JR, LandzbergMJ et al. Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension. Chest, 2001, 120: 866-72.
Foley RJ, Metersky ML. Successful treatment of sarcoidosis-associated pulmonary hypertension with bosentan. Respiration, 2008, 75: 211-14.
Sharma S, Kashour T, Philipp R. Secondary pulmonary arterial hypertension: treated with endothelin receptor blockade. Tex. Heart Inst. J., 2005, 32: 405-10.
Pitsiou GG, Spyratos D, Kioumis I et al. Sarcoidosis-associated pulmonary hypertension: a role for endothelin receptor antagonists? Ther. Adv. Respir. Dis., 2009, 3: 99-101.
Robert P. Baughman MD, Daniel A. et al. Concise Review of Pulmonary Sarcoidosis. 3AJRCCM Articles in Press. Published on October 29, 2010 as doi:10.1164/rccm.201006-0865CI.
DOI: 10.1164/rccm.201006-0865CI
Лебедева Е.В. Функциональное состояние миокарда и особенности гемодинамики малого круга кровообращения у больных саркоидозом легких по данным ЭХОКГ Дисс. канд. наук. СПб., 2004.
Перлей В.Е. Влияние повышенного внутригрудного давления на гемодинамику малого круга кровообращения. Дисс. канд. наук. Л., 1985.
Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Heart J, 2009, 30: 2493-2537.
Амосов В.И., Сперанская А.А., Лукина О.В., Бобров Е.И. Мультиспиральная компьютерная томография в клиниках медицинского унивеситета. СПб.: ЭЛБИ-СПб., 2009.